A resolution expressing support for the designation of April 2023 as "Parkinson's Awareness Month".
By officially designating a month to raise awareness about Parkinson's disease, the resolution seeks to highlight the importance of understanding the disease and recognizing the plight of those it affects. It aims to foster a collective commitment from the Senate to advocate for more funding and resources directed towards research and improved treatments. The economic burden of the disease, estimated at $80 billion annually, underscores the necessity for enhanced public and private efforts to manage and ultimately eradicate this condition.
SR184 is a resolution brought forth in the Senate to express support for the designation of April 2023 as 'Parkinson's Awareness Month'. The resolution outlines the growing impact of Parkinson's disease, which affects over a million individuals in the United States and is increasingly recognized as the second most common neurodegenerative disease, with projections indicating the number of affected individuals will nearly double by 2037. The bill emphasizes the need for continued efforts in research, education, and community support to address the challenges faced by those living with Parkinson's disease and their caregivers.
While SR184 is primarily a resolution of support, potential contention may arise surrounding the allocation of funding and resources for Parkinson's disease research versus other health initiatives. Critics may argue that designating a specific month without accompanying financial commitments could dilute the urgency of addressing Parkinson's disease amidst a plethora of other health concerns. However, the resolution also aims to commend the efforts of researchers and volunteers currently working towards better treatments, indicating a cooperative stand rather than a divisive issue.